Carnitine acyltransferases are not changed in Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 2, 1998, Pages 71-76

  Maurer, Iris ^a,d   Zierz, Stephan ^b   Möller, Hans Jürgen ^c  

^a UNIVERSITY OF BONN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Alzheimer disease; Carnitine acetyltransferase; Carnitine octanoyltransferase; Carnitine palmitoyltransferase; Fatty acid transport

Indexed keywords

CARNITINE ACETYLTRANSFERASE; CARNITINE ACYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; MALONYL COENZYME A; TRITON X 100;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID TRANSPORT; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 0032459162     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199806000-00003     Document Type: Article

References (37)

1. A'Bhaird N, Ramsay RR. Malonyl-CoA inhibition of peroxisomal carnitine octanoyltransferase. Biochem J 1992;286:637-40.
2. Angelucci L, Ramacci MT, Taglialatela G, et al. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J Neurosci Res 1988;20:491-6.
3. Arienti G, Ramacci MT, Maccari F, Casu A, Corazzi L. Acetyl-L-carnitine influences the fluidity of brain microsomes and of liposomes made of rat brain microsomal lipid extracts. Neurochem Res 1992;7:671-5.
4. Bieber LL. Carnitine. Annu Rev Biochem 1988;57:261-83.
5. Bird MI, Saggerson ED. Binding of malonyl-CoA to isolated mitochondria. Evidence for high-and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity. Biochem J 1984;222:639-47.
6. Blum K, Seifter E, Seifter J. The pharmacology of D-and L-carnitine and D-and L-acetyl-carnitine: comparison with choline and acetylcholine. J Pharmacol Exp Ther 1971;178:331-8.
7. Bremer J. The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim Biophys Acta 1981;665:628-31.
8. Bresolin N, Freddo L, Vergani L, Angelini C. Carnitine, carnitine acyltransferases, and rat brain function. Exp Neurol 1982;78:285-92.
9. Cook GA. Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in K. J Biol Chem 1984;259:12030-3.
10. Declercq PE, Falck JR, Kuwajima K, Tyminski K, Foster DW, McGarry JD. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem 1987;262: 9812-21.
11. Dolezal V, Tucek S. Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J Neurochem 1981;36:1323-30.
12. Farrell SO, Fiol CJ, Reddy JK, Bieber LL. Properties of purified carnitine acyltransferases of mouse liver peroxisomes. J Biol Chem 1984; 259:13089-95.
13. Fritz IB Schultz SK, Srere PA. Properties of partially purified carnitine acetyltransferase. J Biol Chem 1963;238:2509-17.
14. Fritz IB, Marquis NR. The role of acylcarnitine esters and carnitine palmitoyltransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc NatAcad Sci USA 1965;54:1226-33.
15. Harsing LG, Sershen H, Toth E, Hashim A, Ramacci MT, Lajtha A. Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study. Eur J Pharmacol 1992;218:117-21.
16. Kalaria RN, Harik SI. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease. Ann Neurol 1992;32:583-6.
17. Kolodzicj MP, Zammit VA. Sensitivity of inhibition of rat liver outer membrane carnitine palmitoyltransferase by malonyl-CoA to chemical-and temperature-induced changes in membrane fluidity. Biochem J 1990;272:421-5.
18. Kopec B, Fritz IB. Comparison of properties of carnitine palmitoyltransferase I with those of carnitine palmitoyltransferase II and preparation of antibodies to carnitine palmitoyltransferases. J Biol Chem 1973;248:4069-74.
19. Lilienthal JL, Zierler KL, Folk BP, Buka R, Riley MJ. A reference base and system for analysis of muscle constituents. J Biol Chem 1950;182:501-8.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin reagent. J Biol Chem 1951;193:265-75.
21. Maccari F, Arseni A, Chiodi P, Ramacci MT, Angelucci L. Levels of carnitines in brain and other tissues of rats of different ages: effect of acetyl-L-carnitine administration. Exp Gerontol 1990;25:127-34.
22. Makar TK, Cooper AJL, Tofel-Grehl B, Thaler HT, Blass JP. Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res 1995;6:705-11.
23. McMillin JB, Taffet GE, Taegtmeyer H, Hudson EK, Tate CA. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc Res 1993;27:2222-8.
24. Moret C, Pastrie I, Briley M. Carnitine acetyltransferase activity is not changed with age in rat brain and human platelets. Neurobiol Aging 1990;11:57-9.
25. Murthy MSR, Pande SV. Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes. Biochem J 1987;248:727-33.
26. Neumann-Schmidt S, Zierz S. Carnitine acyltransferases in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency. Neuromusc Dis 1991;1:253-60.
27. Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH. Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett 1980;18: 105-10.
28. Ramsay RR, Arduini A. The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys 1993;302:307-14.
29. Saggerson ED, Carpenter CA. Effects of fasting, adrenalectomy and streptozotocin-diabetes on sensitivity of hepatic carnitine acyltransferase to malonyl-CoA. FEBS Lett 1981;129:225-8.
30. Saggerson D. Carnitine palmitoyltransferase in extrahepatic tissues. Biochem Soc Trans 1986;14:679-81.
31. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 1992;49:1137-41.
32. Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 1991;41:1726-32.
33. Villa RF, Turpeenoja L, Benzi G, Stella AMG. Action of acetylcarnitine on age-dependent modifications of mitochondrial membrane proteins from rat cerebellum. Neurochem Res 1988;13:909-16.
34. Woeltje KF, Kuwajima K, Foster DW, McGarry JD. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. J Biol Chem 1987;262:9822-7.
35. Woeltje KF, Esser V, Weis BC, et al. Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system. J Biol Chem 1990;265:10714-9.
36. Zierz S, Engel AG. Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem 1985;149:207-14.
37. Zierz S, Engel AG. Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. Biochem J 1987;245:205-9.